Go
Home
Alzheimer's Daily News
The Alzheimer's Store
Alzheimer's Library
Wandering
Alzheimer's Daily News
Subscribe to The
Alzheimer's Daily News
Enter your e-mail address in the box to join.
September 1, 2010
Calendar of Events
Alzheimer's Daily News Archive
Resources
RSS Feed
Today's News
Thursday, September 2, 2010
Brain Exercise May Worsen Existing Alzheimer's
(Source: Neurology) - Keeping mentally active may help stave off Alzheimer's disease, but once patients are diagnosed with the condition, "brain exercise" may actually speed up cognitive decline, researchers said.
(Read More...)
Finding Suggests New Aim for Alzheimer's Drugs
(Source: New York Times) - In a year when news about Alzheimer's disease seems to alternate between encouraging and disheartening, a new discovery by an 84-year-old scientist has illuminated a new direction.
(Read More...)
Drug-Candidate Effective in Alzheimer's Disease Model
(Source: Marketwire) - Addex Pharmaceuticals announced that it has observed efficacy in a model of Alzheimer's disease using a recently discovered available drug-candidate. The proprietary molecule inhibits a receptor called the metabotropic glutamate receptor 2 (mGluR2) via negative allosteric modulation (NAM).
(Read More...)
Eisai Announces Start of Clinical Study of BAN2401
(Source: Marketwatch) - Pharmaceutical company Eisai announced the start of the first patient enrolled clinical study of BAN2401, a novel monoclonal antibody being developed as a potential treatment for Alzheimer's disease.
(Read More...)
JK Rowling Donates Millions for Neurological Research Clinic
(Source: Luxist) -
Harry Potter
author J.K. Rowling has donated more than $15 million for research on degenerative neurological conditions and diseases. The neurology clinic will be based at the University of Edinburgh and will research a variety of diseases, including Alzheimer's and Parkinson's.
(Read More...)
Copyright © 1999-2010 Ageless Design Research Foundation
About Us
|
Contact Us
|
Site Map
|
Log In
3197 Trout Place Road | Cumming, GA 30041 | 1.800.752.3238